Try our mobile app

Switch to company model in classical logic    *

General information

Country: INDIA

Sector: Drug Manufacturers — Specialty and Generic

Dr. Reddy`s Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Dr. Reddy`s Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosage with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. It also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Proprietary Products segment focuses on the research, development, and manufacture of differentiated formulations for dermatology and neurology therapeutic areas. The company also engages in developing therapies in the fields of oncology and inflammation...
Website: drreddys.com



Growth: Good revenue growth rate >200%, there is acceleration compared to average historical growth rates 28.4%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of -24.0%

Profitability: LTM EBITDA margin is positive, +1 494.4%. On average the margin is improving unsteadily. Gross margin is high, +59.2%. In the last quarter the company beat the estimated EPS, +9.4%. The company was ahead of estimated EPS in 80% of quarters (showing a gain of +$0.10 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 1.3%. Free cash flow yield -1.2% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 54.4% higher than minimum and 3.9% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 78.3x by EV / Sales multiple , the company can be >100% undervalued

Key Financials (Download financials)

Ticker: RDY
Share price, USD:  (+0.7%)74.55
year average price 67.35  


year start price 60.46 2023-04-28

min close price 53.34 2023-05-18

max close price 77.59 2024-02-23

current price 74.55 2024-04-26
Common stocks: 165 103 858

Dividend Yield:  1.3%
FCF Yield LTM: -1.2%
EV / LTM EBITDA: 0.2x
EV / EBITDA annualized: 0.1x
Last revenue growth (y/y):  > 200.0%
Last growth of EBITDA (y/y):  > 200.0%
Historical revenue growth:  28.4%
Historical growth of EBITDA:  60.7%
EV / Sales: 2.5x
Margin (EBITDA LTM / Revenue): 1 494.4%
Fundamental value created in LTM:
Market Cap ($m): 12 308
Net Debt ($m): 226
EV (Enterprise Value): 12 534
Price to Book: 3.8x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-04-18Zacks Investment Research

3 Generic Drug Stocks to Watch Amid Challenging Market Prospects

2024-03-20Zacks Investment Research

Here's Why Doctor Reddy's (RDY) is a Strong Value Stock

2024-02-28Zacks Investment Research

Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term

2024-02-23Zacks Investment Research

Here's Why Doctor Reddy's (RDY) is a Strong Momentum Stock

2024-02-22Zacks Investment Research

Why Doctor Reddy's (RDY) is a Top Growth Stock for the Long-Term

2024-02-05Zacks Investment Research

Why Doctor Reddy's (RDY) is a Top Momentum Stock for the Long-Term

2024-02-01Zacks Investment Research

Dr. Reddy's (RDY) Q3 Earnings and Revenues Surpass Estimates

2024-01-08Zacks Investment Research

Here's Why Doctor Reddy's (RDY) is a Strong Growth Stock

2024-01-03Zacks Investment Research

How to Identify Stock Market Winners Early in 2024

2023-12-08Zacks Investment Research

Here's Why Doctor Reddy's (RDY) is a Strong Momentum Stock
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-10
symbol RDY RDY RDY RDY RDY RDY
reportedCurrency INR INR INR INR INR INR
cik 1M 1M 1M 1M 1M 1M
fillingDate 2023-12-31 2023-09-30 2023-06-30 2023-06-13 2022-12-31 2022-09-12
acceptedDate 2023-12-30 19:00:00 2023-09-30 00:00:00 2023-06-30 00:00:00 2023-06-13 16:06:43 2022-12-30 19:00:00 2022-09-12 06:21:46
calendarYear 2024.000 2024.000 2024.000 2023.000 2023.000 2023.000
period Q3 Q2 Q1 Q4 Q3 Q2
revenue 72 148M 68 802M 67 384M 62 969M 67 700M 63 057M
costOfRevenue 29 945M 28 434M 27 831M 11 314M 27 607M 25 810M
grossProfit 42 203M 40 368M 39 553M 51 655M 40 093M 37 247M
grossProfitRatio 0.585 0.587 0.587 0.820 0.592 0.591
researchAndDevelopmentExpenses 5 565M 5 447M 4 984M 5 366M 4 821M 4 869M
generalAndAdministrativeExpenses 0 0 0 12 760M 0 0
sellingAndMarketingExpenses 0 0 0 15 532M 0 0
sellingGeneralAndAdministrativeExpenses 20 228M 18 795M 17 702M 28 292M 17 981M 16 560M
otherExpenses 0 0 0 -2 394M 800M -423M
operatingExpenses 25 297M 22 883M 21 906M 31 264M 23 602M 21 006M
costAndExpenses 55 242M 51 317M 49 737M 42 578M 51 209M 46 816M
interestIncome 583M 719M 329M 474M 2 695M 216M
interestExpense 394M 353M 371M 354M 419M 309M
depreciationAndAmortization 3 770M 3 789M 22M 3 055M 2 822M 3 596M
ebitda 21 286M 22 035M 17 658M 25 007M 19 247M 19 723M
ebitdaratio 0.295 0.320 0.262 0.397 0.284 0.313
operatingIncome 17 267M 17 867M 17 636M 21 952M 16 425M 16 127M
operatingIncomeRatio 0.239 0.260 0.262 0.349 0.243 0.256
totalOtherIncomeExpensesNet 1 162M 1 283M 32M -8 661M -79M -16M
incomeBeforeTax 18 257M 19 134M 18 463M 13 291M 16 346M 16 111M
incomeBeforeTaxRatio 0.253 0.278 0.274 0.211 0.241 0.255
incomeTaxExpense 4 468M 4 334M 4 438M 3 690M 3 875M 4 983M
netIncome 13 789M 14 800M 14 025M 9 601M 12 471M 11 128M
netIncomeRatio 0.191 0.215 0.208 0.152 0.184 0.176
eps 82.810 88.960 84.210 57.790 75.530 67.400
epsdiluted 82.680 88.780 84.210 57.680 74.960 66.890
weightedAverageShsOut 167M 166M 167M 166M 165M 165M
weightedAverageShsOutDil 167M 167M 167M 166M 166M 166M
link Link Link
finalLink Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-10
symbol RDY RDY RDY RDY RDY RDY
reportedCurrency INR INR INR INR INR INR
cik 1M 1M 1M 1M 1M 1M
fillingDate 2023-12-31 2023-09-30 2023-06-30 2023-06-13 2022-12-31 2022-09-12
acceptedDate 2023-12-30 19:00:00 2023-09-30 00:00:00 2023-06-30 00:00:00 2023-06-13 16:06:43 2022-12-30 19:00:00 2022-09-12 06:21:46
calendarYear 2024.000 2024.000 2024.000 2023.000 2023.000 2023.000
period Q3 Q2 Q1 Q4 Q3 Q2
cashAndCashEquivalents 7 342M 13 391M 6 017M 5 779M 6 259M 9 096M
shortTermInvestments 65 015M 54 390M 53 032M 60 969M 42 241M 18 479M
cashAndShortTermInvestments 72 357M 67 781M 61 162M 66 748M 50 164M 27 575M
netReceivables 96 078M 89 693M 77 248M 72 485M 77 338M 80 052M
inventory 60 796M 56 592M 52 398M 48 670M 49 326M 49 042M
otherCurrentAssets 4 215M 1 000 000 18 512M 15 120M 19 142M 18 329M
totalCurrentAssets 238 477M 217 695M 113 560M 204 255M 49 326M 175 606M
propertyPlantEquipmentNet 72 795M 70 478M 67 207M 56 542M 64 996M 63 817M
goodwill 4 287M 4 223M 4 238M 5 474M 4 495M 4 328M
intangibleAssets 36 905M 37 055M 38 068M 30 724M 30 906M 31 756M
goodwillAndIntangibleAssets 41 192M 41 278M 42 306M 36 198M 35 401M 36 084M
longTermInvestments 8 333M 5 924M 4 904M 6 089M 6 279M 6 107M
taxAssets 10 917M 10 835M 9 544M 7 052M 6 306M 7 559M
otherNonCurrentAssets 1 128M 812M -14 448M 12 715M -12 585M 1 801M
totalNonCurrentAssets 134 365M 129 327M 109 513M 118 596M 100 397M 115 368M
otherAssets 0 0 111 967M 0 159 577M 0
totalAssets 372 842M 347 022M 335 040M 322 851M 309 300M 290 974M
accountPayables 31 113M 30 485M 55 364M 22 684M 26 023M 22 778M
shortTermDebt 13 699M 7 187M 7 590M 12 194M 16 206M 15 494M
taxPayables 4 174M 3 985M 4 432M 2 143M 1 333M 1 257M
deferredRevenue 2 269M 3 001M 47 774M 1 981M 0 0
otherCurrentLiabilities 46 519M 43 510M -55 364M 48 862M -16 206M 41 759M
totalCurrentLiabilities 93 600M 84 183M 55 364M 85 721M 26 023M 80 031M
longTermDebt 6 152M 6 043M 4 930M 1 278M 1 457M 1 795M
deferredRevenueNonCurrent 1 444M 1 497M 60M 1 555M 0 0
deferredTaxLiabilitiesNonCurrent 989M 102M 642M 760M 160M 46M
otherNonCurrentLiabilities 2 807M 2 111M 3 382M 676M 24 406M -33 554M
totalNonCurrentLiabilities 11 392M 9 753M 9 014M 4 269M 26 023M 4 718M
otherLiabilities 0 0 -9 014M 0 0 0
capitalLeaseObligations 3 708M 3 579M 2 252M 1 278M 2 395M 2 716M
totalLiabilities 104 992M 93 936M 55 364M 89 990M 52 046M 84 749M
preferredStock 0 0 0 0 0 0
commonStock 834M 834M 833M 833M 833M 832M
retainedEarnings 252 078M 238 226M 230 020M 215 593M 206 714M 194 165M
accumulatedOtherComprehensiveIncomeLoss 762M 810M 864M 1 266M 553M 631M
othertotalStockholdersEquity 14 176M 13 216M 13 542M 15 169M 12 173M 10 597M
totalStockholdersEquity 267 850M 253 086M 245 259M 232 861M 220 273M 206 225M
totalEquity 267 850M 253 086M 245 259M 232 861M 220 273M 206 225M
totalLiabilitiesAndStockholdersEquity 372 842M 347 022M 335 040M 322 851M 309 300M 290 974M
minorityInterest 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 372 842M 347 022M 335 040M 322 851M 309 300M 290 974M
totalInvestments 73 348M 60 314M 57 936M 67 058M 48 520M 24 586M
totalDebt 19 851M 13 230M 12 520M 13 472M 17 663M 17 289M
netDebt 12 509M -161M 6 503M 7 693M 11 404M 8 193M
link Link Link
finalLink Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-10
symbol RDY RDY RDY RDY RDY RDY
reportedCurrency INR INR INR INR INR INR
cik 1M 1M 1M 1M 1M 1M
fillingDate 2023-12-31 2023-09-30 2023-06-30 2023-06-13 2022-12-31 2022-09-12
acceptedDate 2023-12-30 19:00:00 2023-09-30 00:00:00 2023-06-30 00:00:00 2023-06-13 16:06:43 2022-12-30 19:00:00 2022-09-12 06:21:46
calendarYear 2024.000 2024.000 2024.000 2023.000 2023.000 2023.000
period Q3 Q2 Q1 Q4 Q3 Q2
netIncome 13 789M 14 800M 14 025M 25 010M 12 471M 11 128M
depreciationAndAmortization 3 770M 3 789M 3 569M 3 055M 3 271M 3 126M
deferredIncomeTax 4 468M 4 334M 4 438M 3 663M 3 875M 4 983M
stockBasedCompensation 99M 103M 108M 21M 113M 117M
changeInWorkingCapital -11 855M 2 609M -8 174M 2 478M 6 024M -9 784M
accountsReceivables -8 826M 7 336M 0 0 0 0
inventory -5 203M -4 702M -4 638M -4 212M -284M 2 768M
accountsPayables 8 826M -7 336M 0 0 0 0
otherWorkingCapital -6 652M 7 311M -3 536M 6 690M 6 308M -12 552M
otherNonCashItems -5 534M -7 709M -2 716M -14 550M -2 494M -289M
netCashProvidedByOperatingActivities 4 737M 17 926M 11 250M 19 677M 23 260M 9 281M
investmentsInPropertyPlantAndEquipment -5 042M -3 939M -12 171M -3 746M -3 099M -3 329M
acquisitionsNet 5 042M 3 939M 12 171M 0 0 0
purchasesOfInvestments -35 166M -40 399M -29 609M -48 464M -40 699M -19 871M
salesMaturitiesOfInvestments 23 203M 38 651M 33 164M 36 191M 17 219M 28 753M
otherInvestingActivites -4 217M -2 769M -11 791M 248M 169M 180M
netCashUsedForInvestingActivites -16 180M -4 517M -8 236M -15 771M -26 410M 5 733M
debtRepayment -697M -587M -4 791M -15 252M -1 094M -17 082M
commonStockIssued 9M 686M 79M 221M 81M 35M
commonStockRepurchased 0 0 0 0 0 0
dividendsPaid 0 -6 648M 0 0 0 -4 979M
otherFinancingActivites 5 970M -487M 3 236M 10 733M 1 596M 9 680M
netCashUsedProvidedByFinancingActivities 5 282M -7 036M -1 476M -4 298M 583M -12 346M
effectOfForexChangesOnCash 161M -66M -89M -88M -267M 128M
netChangeInCash -6 000M 6 307M 1 449M -480M -2 834M 2 796M
cashAtEndOfPeriod 7 535M 13 535M 7 228M 5 779M 6 259M 9 093M
cashAtBeginningOfPeriod 13 535M 7 228M 5 779M 6 259M 9 093M 6 297M
operatingCashFlow 4 737M 17 926M 11 250M 19 677M 23 260M 9 281M
capitalExpenditure -5 042M -3 939M -12 171M -3 746M -3 099M -3 329M
freeCashFlow -305M 13 987M -921M 15 931M 20 161M 5 952M
link Link Link
finalLink Link Link

Earning call transcript

2023 q4
2024-01-30 ET (fiscal 2024 q3)
2023 q3
2023-10-27 ET (fiscal 2024 q2)
2023 q2
2023-07-26 ET (fiscal 2024 q1)
2023 q1
2023-05-11 ET (fiscal 2023 q4)
2022 q4
2023-01-25 ET (fiscal 2023 q3)
2022 q3
2022-10-28 ET (fiscal 2023 q2)
2022 q2
2022-07-31 ET (fiscal 2023 q1)
2022 q1
2022-05-19 ET (fiscal 2022 q4)
2021 q4
2022-01-28 ET (fiscal 2022 q3)

Press-releases

Show financial reports only

2024-01-31 14:44 ET
Dr. Reddy’s Q3 & 9M FY24 Financial Results
2024-01-04 06:58 ET
Dr. N. Krishna Reddy appointed CEO and Dr. Sten Vermund inducted to ACCESS Health International's Board of Directors
2024-01-03 11:00 ET
Dr. Reddy's Announces the Acquisition of MenoLabs®, a Leading Women’s Health and Dietary Supplements Portfolio of Brands
2023-12-14 12:49 ET
Dr. Reddy’s becomes first Indian pharma company to debut on the Dow Jones Sustainability World Index
2023-12-06 12:00 ET
Coya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter into an Exclusive Collaboration for Development and Commercialization of COYA 302, an Investigational Combination Therapy for Treatment of Amyotrophic Lateral Sclerosis (ALS)
2023-10-27 17:50 ET
Dr. Reddy’s Q2 FY24 Financial Results
2023-08-10 11:00 ET
Dr. Reddy's Laboratories Announces its Launch of Saxagliptin and Metformin Hydrochloride Extended-Release Tablets in the U.S.
2023-07-26 16:31 ET
Dr. Reddy’s Q1 FY24 Financial Results
2023-07-12 14:25 ET
Dr. Reddy’s Proposed Rituximab Biosimilar Application Accepted for Review by USFDA, EMA and MHRA
2023-06-05 11:00 ET
Dr. Reddy’s Successfully Completes Phase I Study (IV Route) of DRL_TC, a Proposed Biosimilar of Tocilizumab
2023-05-10 15:43 ET
Dr. Reddy’s Q4 & FY23 Financial Results
2023-05-05 11:17 ET
Dr. Reddy's Laboratories Announces the Launch of Regadenoson Injection 0.4 mg/5 mL in the U.S.
2023-04-21 11:15 ET
Dr. Reddy's Laboratories Announces the Launch of Treprostinil Injection in the U.S.
2023-03-20 11:00 ET
Coya Therapeutics, Inc. Announces an Agreement with Dr. Reddy’s Laboratories, Ltd. to License its proposed biosimilar Abatacept for the Development and Commercialization of COYA 302 for the Treatment of Neurodegenerative Diseases
2023-02-27 11:00 ET
Dr. Reddy's Laboratories Announces Agreement to Acquire Mayne Pharma’s U.S. Generic Prescription Product Portfolio
2023-02-08 13:50 ET
Dr. Reddy’s included in Bloomberg Gender-Equality Index for the 6th year in a row and S&P Global’s Sustainability Yearbook for the 3rd year
2023-01-27 12:03 ET
Dr. Reddy's Laboratories announces the launch of Difluprednate Ophthalmic Emulsion 0.05% in the U.S. Market
2023-01-20 11:30 ET
Dr. Reddy’s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe
2022-12-19 13:00 ET
Dr. Reddy’s Successfully Completes Phase 1 Study of DRL_TC, a Proposed Biosimilar of Tocilizumab
2022-10-11 11:57 ET
World Economic Forum Recognises Dr. Reddy’s Hyderabad Factory as Part of its Global Lighthouse Network
2022-09-07 17:28 ET
Dr. Reddy's Laboratories Announces the Launch of Lenalidomide Capsules in the U.S. With Two of Six Strengths Eligible for First-to-market, 180-day Exclusivity
2022-07-29 17:24 ET
Dr. Reddy's Laboratories enters into a licensing agreement with Slayback Pharma to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify® in the U.S.
2022-07-27 07:26 ET
Dr. Reddy's Laboratories announces the launch of Bortezomib for Injection, 3.5 mg Single-Dose Vial in the U.S. Market
2022-07-22 10:17 ET
Dr. Reddy’s Announces the First-to-Market Launch of Over-the-Counter, Store-Brand Equivalent of Allegra-D® 24 Hr in the U.S. Market
2022-07-08 15:48 ET
Dr. Reddy's Laboratories Announces the Launch of Fesoterodine Fumarate Extended-Release Tablets in the U.S. Market
2022-07-05 07:30 ET
Aurigene Discovery Technologies Limited Announces Drug Discovery, Development and Commercialization Partnership with EQRx
2022-06-14 06:51 ET
Dr. Reddy's Laboratories announces the launch of the generic version of Nexavar (sorafenib) Tablets, USP, 200 mg in the U.S. market
2022-05-27 14:15 ET
Dr. Reddy's Laboratories Announces the Launch of Pemetrexed for Injection USP, in the U.S. Market
2022-05-24 17:40 ET
Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. announce the launch of Ketorolac Tromethamine Tablets USP, 10 mg in the U.S. market
2022-04-20 16:41 ET
Dr. Reddy's Laboratories Announces the Launch of Posaconazole Delayed-Release Tablets in the U.S. Market
2022-04-05 10:52 ET
Dr. Reddy's Laboratories Announces the Launch of Methylprednisolone Sodium Succinate for Injection, USP in the U.S. Market
2022-04-01 12:00 ET
Dr. Reddy's Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in Germany
2022-02-09 14:17 ET
Dr. Reddy's Laboratories Announces the Launch of Its Authorized Generic Version of VASOSTRICT® (vasopressin injection, USP) Vials in the U.S. Market
2022-02-03 14:33 ET
Dr. Reddy's Laboratories Enters Into Definitive Agreement to Acquire German Medical Cannabis Firm Nimbus Health GmbH
2022-02-02 09:15 ET
Dr. Reddy’s Included in S&P Global’s Sustainability Yearbook for the 2nd Year and Bloomberg Gender-Equality Index for the 5th Year in a Row
2021-12-10 04:47 ET
Dr. Reddy's Laboratories Announces the Launch of Venlafaxine ER Tablets in the U.S. Market
2021-12-09 08:18 ET
Dr. Reddy's Laboratories Announces the Launch of Valsartan Tablets, USP in the U.S. Market
2021-12-09 05:50 ET
Prestige BioPharma and Dr. Reddy’s announce partnership to commercialize trastuzumab biosimilar in select countries in Latin America and Southeast Asia
2021-12-09 02:00 ET
Prestige BioPharma and Dr. Reddy’s announce partnership to commercialize trastuzumab biosimilar in select countries in Latin America and Southeast Asia
2021-10-29 12:59 ET
Dr. Reddy's Laboratories Announces the Launch of Ephedrine Sulfate Injection USP, 50 mg/mL, Single-Dose Vial in the U.S. Market
2021-10-15 17:40 ET
Dr. Reddy's Laboratories Announces the Launch of Carmustine for Injection, USP in the U.S. Market
2021-09-09 12:30 ET
Beroni Group Received Approval for 43.5% R&D Rebate from Australian Government for the Novel, Potential Anti-Cancer Drug PENAO
2021-09-04 05:11 ET
Dr. Reddy’s Laboratories enters into definitive agreement with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox)
2021-09-02 04:12 ET
Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian Market
2021-08-31 06:43 ET
Dr. Reddy's Laboratories Announces the Launch of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP in the U.S. Market
2021-08-18 12:30 ET
Beroni Initiates Manufacture of its Novel, Potential Anti-Cancer Drug PENAO
2021-08-04 14:32 ET
Dr. Reddy’s Laboratories Announces Entry Into Definitive Agreement with BioDelivery Sciences International, Inc., to Sell its U.S. and Canada Territory Rights for ELYXYB (celecoxib oral solution) 25 mg/mL
2021-08-03 12:32 ET
Dr. Reddy’s Announces the Re-Launch of Over-the-Counter Naproxen Sodium Tablets USP, 220 mg, Store-Brand Equivalent of Aleve® in the U.S. Market

SEC forms

Show financial reports only

SEC form 6
2024-04-19 10:34 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-19 10:34 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-19 07:22 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-19 07:22 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-18 10:54 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-18 10:54 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-15 06:06 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-15 06:06 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-10 09:04 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-10 09:04 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-05 09:42 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-04-05 09:42 ET
Dr. Reddy's Laboratories Limited published news for 2024 q1
SEC form 6
2024-03-27 08:37 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-27 08:37 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-22 07:51 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-22 07:51 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-22 07:41 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-22 07:41 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-19 06:17 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-19 06:17 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-15 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-15 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-14 13:51 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-14 13:51 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-14 13:48 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-14 13:48 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-13 07:51 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-13 07:51 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-12 14:20 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-12 14:20 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-04 06:16 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-04 06:16 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-01 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-03-01 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-29 06:57 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-29 06:57 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-29 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-29 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-26 06:41 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-26 06:41 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-23 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-23 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-21 08:43 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-21 08:43 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-20 06:20 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-02-20 06:20 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-19 10:00 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-19 10:00 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-16 13:41 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-16 13:41 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-16 11:34 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-16 11:34 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-16 06:10 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-16 06:10 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-10 08:19 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-10 08:19 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-08 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-08 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-03 06:11 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-03 06:11 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-02 06:36 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-02 06:36 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-02 06:28 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2024-01-02 06:28 ET
Dr. Reddy's Laboratories Limited published news for 2023 q4
SEC form 6
2023-12-29 08:39 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-29 08:39 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-29 07:16 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-29 07:16 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-21 06:11 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-21 06:11 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-15 06:14 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-15 06:14 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-12 06:09 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-12 06:09 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-11 06:18 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-11 06:18 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-08 12:35 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-08 12:35 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-06 11:30 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-06 11:30 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-01 07:12 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-12-01 07:12 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-11-28 08:59 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-11-28 08:59 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-10-27 13:19 ET
Dr. Reddy's Laboratories Limited reported for 2023 q3
SEC form 6
2023-10-26 09:19 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-10-16 15:44 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-10-16 11:34 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-10-12 11:47 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-10-10 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2023 q3
SEC form 6
2023-09-28 13:29 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-09-28 13:23 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-09-22 07:55 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-09-19 14:38 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-09-19 14:28 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-09-18 06:17 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-09-07 07:27 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-09-06 06:14 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-09-05 21:49 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-08-29 07:15 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-27 06:15 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-27 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-26 18:11 ET
Dr. Reddy's Laboratories Limited reported for 2023 q2
SEC form 6
2023-07-26 14:56 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-21 06:16 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-19 11:18 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-18 06:10 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-17 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-12 10:27 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-06 09:07 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-07-03 07:48 ET
Dr. Reddy's Laboratories Limited published news for 2023 q2
SEC form 6
2023-06-23 07:47 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-06-23 06:06 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-06-20 06:52 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-06-20 06:35 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-06-14 09:26 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-06-13 16:06 ET
Dr. Reddy's Laboratories Limited reported for 2023 q1
SEC form 6
2023-06-12 21:54 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-06-05 06:06 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-06-01 07:50 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-05-22 09:04 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-05-16 06:21 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-05-15 06:36 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-05-12 06:13 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-05-10 17:20 ET
Dr. Reddy's Laboratories Limited reported for 2023 q1
SEC form 6
2023-05-10 12:02 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-04-07 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2023 q1
SEC form 6
2023-03-24 06:20 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-03-24 06:15 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-03-21 08:16 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-03-16 13:12 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-03-13 08:26 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-02-28 12:19 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-02-27 06:46 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-02-16 21:17 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-02-08 20:38 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-02-03 11:47 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-01-30 10:17 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-01-27 09:41 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-01-26 18:26 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-01-26 11:51 ET
Dr. Reddy's Laboratories Limited reported for 2022 q4
SEC form 6
2023-01-25 14:51 ET
Dr. Reddy's Laboratories Limited reported for 2022 q4
SEC form 6
2023-01-25 14:48 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-01-25 13:38 ET
Dr. Reddy's Laboratories Limited reported for 2022 q4
SEC form 6
2023-01-20 06:17 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-01-13 07:34 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-01-13 06:11 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2023-01-06 12:53 ET
Dr. Reddy's Laboratories Limited published news for 2022 q4
SEC form 6
2022-12-29 06:16 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-12-27 08:34 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-12-27 06:11 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-12-19 07:45 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-12-19 06:19 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-12-16 06:09 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-12-06 21:19 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-11-28 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-11-22 14:07 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-11-16 13:45 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-11-03 13:26 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-11-02 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-10-31 07:43 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-10-31 06:13 ET
Dr. Reddy's Laboratories Limited reported for 2022 q3
SEC form 6
2022-10-28 14:37 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-10-28 14:17 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-10-24 06:14 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-10-13 07:16 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-10-11 13:32 ET
Dr. Reddy's Laboratories Limited published news for 2022 q3
SEC form 6
2022-09-29 10:41 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-09-27 06:38 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-09-23 07:02 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-09-20 13:39 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-09-19 06:51 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-09-12 06:21 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-09-08 06:13 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-09-07 06:17 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-08-26 06:21 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-08-25 06:38 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-08-08 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-08-03 09:12 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-08-01 14:49 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-08-01 12:46 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-08-01 06:21 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-28 21:56 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-28 15:21 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-28 14:26 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-27 08:10 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-22 13:45 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-13 21:50 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-12 06:16 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-08 13:52 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-07 12:41 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-07-07 07:22 ET
Dr. Reddy's Laboratories Limited published news for 2022 q2
SEC form 6
2022-06-30 06:30 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-28 08:51 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-27 15:02 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-24 10:20 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-22 07:13 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-21 06:44 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-21 06:37 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-14 13:26 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-13 13:17 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-09 13:40 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-03 14:29 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-06-02 21:53 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-05-31 06:10 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-05-24 15:47 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-05-24 13:31 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-05-20 21:16 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-05-19 21:52 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-05-19 16:28 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-05-11 06:57 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-04-25 16:06 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-04-22 14:16 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-04-20 13:34 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-04-11 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-04-08 12:06 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-04-07 13:18 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-04-05 06:56 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-04-01 13:36 ET
Dr. Reddy's Laboratories Limited published news for 2022 q1
SEC form 6
2022-03-29 09:33 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-03-17 11:51 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-03-17 08:10 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-28 12:31 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-25 12:41 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-25 06:43 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-22 06:55 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-14 06:38 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-11 13:34 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-09 14:23 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-09 10:34 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-09 06:12 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-07 06:23 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-03 07:50 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-02 06:22 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-02-01 14:01 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-01-31 09:52 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-01-28 11:39 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-01-28 10:34 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-01-28 10:27 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-01-18 13:54 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-01-18 06:17 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-01-10 10:06 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2022-01-07 13:10 ET
Dr. Reddy's Laboratories Limited published news for 2021 q4
SEC form 6
2021-12-28 12:14 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-12-20 06:17 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-12-10 13:39 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-12-10 06:44 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-12-09 07:21 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-11-08 06:39 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-11-08 06:23 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-11-05 14:27 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-11-01 06:34 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-11-01 06:17 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-10-29 15:03 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-10-19 06:18 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-10-18 06:37 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-10-15 12:33 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-10-07 09:22 ET
Dr. Reddy's Laboratories Limited published news for 2021 q3
SEC form 6
2021-09-27 06:06 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-09-22 10:47 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-09-10 06:57 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-09-07 06:23 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-09-07 06:16 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-09-03 12:53 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-09-02 08:07 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-08-31 07:53 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-08-10 10:59 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-08-04 14:59 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-08-03 12:34 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-08-03 08:16 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-08-02 14:42 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-07-29 07:18 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-07-27 12:42 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-07-27 11:58 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-07-27 08:49 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-07-07 08:55 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-07-06 06:29 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-07-02 14:38 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-07-01 06:14 ET
Dr. Reddy's Laboratories Limited published news for 2021 q2
SEC form 6
2021-06-30 11:51 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-06-29 11:52 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-06-28 07:18 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-06-28 07:09 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-06-24 10:48 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-06-22 09:05 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-06-15 14:36 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-06-04 13:43 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-05-24 06:46 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-05-21 08:05 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-05-19 06:23 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-05-17 06:27 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-05-14 15:13 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-05-14 14:22 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-05-12 08:46 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-05-10 07:07 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-05-03 09:20 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-04-29 14:09 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-04-23 13:30 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-04-13 06:54 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-04-07 08:49 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-04-01 14:18 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-04-01 07:05 ET
Dr. Reddy's Laboratories Limited published news for 2021 q1
SEC form 6
2021-03-29 11:43 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-03-22 09:55 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-03-10 06:46 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-03-01 09:58 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-02-22 07:14 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-02-19 08:25 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-02-18 08:08 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-02-17 06:30 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-02-03 11:32 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-02-02 07:15 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-02-01 08:33 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-01-29 08:09 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-01-27 09:07 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-01-15 16:00 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-01-11 13:01 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-01-11 08:47 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2021-01-08 12:50 ET
Dr. Reddy's Laboratories Limited published news for 2020 q4
SEC form 6
2020-12-29 13:00 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-12-28 13:04 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-12-22 07:36 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-12-09 06:20 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-12-08 10:09 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-12-08 09:53 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-11-30 07:11 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-11-19 10:03 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-11-13 10:26 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-30 08:20 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-29 08:49 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-29 07:00 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-28 12:57 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-28 12:34 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-22 09:57 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-20 14:54 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-19 12:35 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-13 12:09 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-05 13:19 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-05 13:12 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3
SEC form 6
2020-10-01 07:52 ET
Dr. Reddy's Laboratories Limited published news for 2020 q3